Daniel Batlle
Correspondence and offprint requests to: Daniel Batlle; E-mail:
Name/email consistency: high
- Genetic causes and mechanisms of distal renal tubular acidosis. Batlle, D., Haque, S.K. Nephrol. Dial. Transplant. (2012)
- Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Wysocki, J., Ye, M., Rodriguez, E., González-Pacheco, F.R., Barrios, C., Evora, K., Schuster, M., Loibner, H., Brosnihan, K.B., Ferrario, C.M., Penninger, J.M., Batlle, D. Hypertension (2010)
- ACE2 and diabetes: ACE of ACEs? Batlle, D., Jose Soler, M., Ye, M. Diabetes (2010)
- New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy. Batlle, D., Soler, M.J., Wysocki, J. Curr. Opin. Nephrol. Hypertens. (2008)
- Distal renal tubular acidosis and the potassium enigma. Batlle, D., Moorthi, K.M., Schlueter, W., Kurtzman, N. Semin. Nephrol. (2006)
- Clinical and cellular markers of diabetic nephropathy. Batlle, D. Kidney Int. (2003)